Literature DB >> 7972034

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.

R A Copeland1, J M Williams, J Giannaras, S Nurnberg, M Covington, D Pinto, S Pick, J M Trzaskos.   

Abstract

Selective inhibition of the inducible isoform of prostaglandin G/H synthase (cyclooxygenase-2; COX2; EC 1.14.99.1) can be achieved with compounds of the general form of aryl methyl sulfonyls and aryl methyl sulfonamides. DuP 697 and NS-398 are representative examples of these compounds. Both inhibit the constitute (COX1) and inducible (COX2) isoforms of the enzyme with equal potency shortly after mixing, but their potencies increase with time for COX2 selectively. This time-dependent inhibition follows first-order kinetics, and the rate constant for inactivation of COX2 is dose dependent for both compounds. Kinetic analysis allows us to determine KI and kinact (the maximal rate of inactivation) for each inhibitor. The potency of both compounds is substrate concentration dependent, as expected for time-dependent competitive inhibitors. COX2 that has been incubated with these inhibitors, and then extensively dialyzed against buffer, shows no recovery of enzyme activity, while complete recovery of activity is seen for COX1. Thus, these inhibitors irreversibly inactivate COX2 with time, while showing minimal reversible inhibition of COX1. We isolated these inhibitors after long incubation with excess enzyme and subsequent denaturation of the enzyme. Both inhibitors showed no loss of potency resulting from interactions with COX2, suggesting that inhibition is not mediated by covalent modification of the enzyme. These data suggest that binding of these inhibitors to COX2 induces a slow structural transition of the enzyme that results in its selective inactivation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972034      PMCID: PMC45195          DOI: 10.1073/pnas.91.23.11202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

2.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

Authors:  M K O'Banion; V D Winn; D A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

4.  Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.

Authors:  B J Whittle; G A Higgs; K E Eakins; S Moncada; J R Vane
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

5.  Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells.

Authors:  J A Maier; T Hla; T Maciag
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

6.  Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme.

Authors:  C Yokoyama; T Tanabe
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

7.  Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

Authors:  K R Gans; W Galbraith; R J Roman; S B Haber; J S Kerr; W K Schmidt; C Smith; W E Hewes; N R Ackerman
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

8.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

9.  Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.

Authors:  R J Kulmacz; W E Lands
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

10.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  49 in total

1.  Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2).

Authors:  R García-Nieto; C Pérez; F Gago
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.

Authors:  M Ouellet; D Riendeau; M D Percival
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors.

Authors:  M C Walker; R G Kurumbail; J R Kiefer; K T Moreland; C M Koboldt; P C Isakson; K Seibert; J K Gierse
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 4.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 5.  The drug-target residence time model: a 10-year retrospective.

Authors:  Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

6.  Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.

Authors:  A S Kalgutkar; B C Crews; S W Rowlinson; A B Marnett; K R Kozak; R P Remmel; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

7.  Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia.

Authors:  Jenny Jacob; Bashi M Babu; Mohind C Mohan; A P Abhimannue; B Prakash Kumar
Journal:  Inflammopharmacology       Date:  2017-02-15       Impact factor: 4.473

8.  Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.

Authors:  Marc Ouellet; Jean-Pierre Falgueyret; M David Percival
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.

Authors:  Gilad Rimon; Ranjinder S Sidhu; D Adam Lauver; Jullia Y Lee; Narayan P Sharma; Chong Yuan; Ryan A Frieler; Raymond C Trievel; Benedict R Lucchesi; William L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

10.  Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.

Authors:  Suzanne Habjan; Robert J Vandenberg
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.